老年男性糖尿病患者骨密度丢失更快:骨质疏松性骨折男性研究(MrOS)
多中心MrOS研究纳入5994名≥65岁男性,分析4095名有随访骨密度者,比较血糖正常、糖尿病前期和2型糖尿病者的髋部骨密度变化。校正后2型糖尿病者髋部骨密度丢失大于血糖正常者,糖尿病前期者无显著差异;2型糖尿病者中使用噻唑烷二酮、胰岛素或磺脲类与更大幅度骨密度丢失相关。
要点
- 2型糖尿病老年男性髋部骨密度丢失大于血糖正常者。
- 糖尿病前期老年男性髋部骨密度丢失与血糖正常者无显著差异。
- 2型糖尿病者中使用噻唑烷二酮、胰岛素或磺脲类与更大幅度髋部骨密度丢失相关。
核心结论
- 2型糖尿病老年男性较血糖正常者经历加速骨丢失,而糖尿病前期者无此表现。
研究设计与样本
- 多中心骨质疏松性骨折男性研究(MrOS)纳入5994名年龄≥65岁男性,本分析纳入4095名有基线及随访双能X线吸收法髋部骨密度且糖尿病状态明确者。
- 糖尿病状态由自我报告、糖尿病药物使用或基线空腹血清葡萄糖升高定义,随访骨密度测量在4.6±0.4年后进行。
主要发现
- 校正模型中,2型糖尿病男性髋部骨密度丢失为-2.23%(95%CI:-2.54至-1.91;P<.001),大于血糖正常者的-1.57%(95%CI:-1.73至-1.41)。
- 糖尿病前期男性髋部骨密度丢失为-1.45%(95%CI:-1.63至-1.26;P=.33),与血糖正常者无显著差异。
- 在2型糖尿病男性中,噻唑烷二酮、胰岛素和磺脲类使用与更大幅度髋部骨密度丢失相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Type 2 diabetes mellitus is associated with more rapid bone loss in women, but less evidence is available for men or those with prediabetes. OBJECTIVE: To determine whether bone loss rate is affected by diabetes status in older men, we analyzed data from the Osteoporotic Fractures in Men (MrOS) study. METHODS: The multisite MrOS study enrolled 5994 men aged ≥ 65 years. Diabetes status was defined by self-report, diabetes medication use, or elevated fasting serum glucose at baseline. Hip bone mineral density (BMD) was measured by dual-energy x-ray absorptiometry (DXA) at baseline and a follow-up visit after 4.6 ± 0.4 years. This analysis included 4095 men, excluding those without follow-up DXA or with unknown diabetes status. Changes in hip BMD in participants with normoglycemia (NG), prediabetes, or type 2 diabetes, excluding thiazolidinedione (TZD) users, were evaluated using generalized linear models (GLM). Diabetes medication use and BMD loss among those with type 2 diabetes were also evaluated with GLM. RESULTS: In adjusted models, hip BMD loss was greater in men with type 2 diabetes (- 2.23%; 95% CI: -2.54 to -1.91; P < .001) but not in men with prediabetes (-1.45%; 95% CI -1.63 to -1.26; P = .33) compared with NG (-1.57%; 95% CI -1.73 to -1.41). Among men with type 2 diabetes, TZD, insulin, and sulfonylurea use were associated with greater hip BMD loss. CONCLUSION: Men with type 2 diabetes, but not prediabetes, experienced accelerated bone loss compared to participants with normoglycemia. More rapid bone loss predicts increased risk of fractures and mortality in broader populations.
引用
- Tramontana F, Napoli N, Litwack-Harrison S, et al. More Rapid Bone Mineral Density Loss in Older Men With Diabetes: The Osteoporotic Fractures in Men (MrOS) Study. J Clin Endocrinol Metab. 2024. PMID: 38407631. doi:10.1210/clinem/dgae045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。